Sunday, 10 December

NIHR awards £10m in funding to fight non-communicable diseases in West Africa

Health News
From left to right: Prof. Mirzoev (LSHTM), UK; Baperman Abdel Aziz Siri, MOH rep from B. Faso, Prof Agyepong (GCPS), Dr Diarra, (LASDEL), Niger; Prof. Owusu-Ansah (Ashesi)

The National Institute for Health and Care Research (NIHR), United Kingdom (UK) and the Department of Health and Social Care, UK, have scaled up efforts to combat Non-Communicable Diseases (NCDs) with approximately £10 million in funding for NCD research in Ghana, Burkina Faso and Niger.

NIHR, an institution at the forefront of tackling health issues, will provide support for the establishment of a Global Health Research Centre for Non-Communicable Disease control in West Africa to address the scourge of NCDs over a five-year period.

The centre will also develop the skills of local researchers and clinicians and will run a PhD and master’s programme to provide formal training for students in all three countries.

The centre will comprise the Ghana College of Physicians and Surgeons (GCPS) and the London School of Hygiene and Tropical Medicine (LSHTM) as the co-lead institutions working in partnership with other institutions, namely Ashesi University, Ghana; Catholic University of West Africa (UCAO-UUB), Burkina Faso; and Laboratoire d’Etudes et de Recherche sur les Dynamiques Sociales et le Développement Local (LASDEL), Niger.

Dr Sylvia Anie, National Institute for Health and Care Research, UK, commented, “NIHR Global Health Research Centres will provide a sustainable platform for high-quality applied health research in low-and low middle-income countries (LMIC) to address the burden of NCDs and improve health outcomes. It is time to shift the centre of gravity to LMIC-led research.”

NCDs, also known as chronic diseases, are not passed from person to person. They include heart disease, stroke, cancer, diabetes and chronic lung disease.

Across the world, NCDs kill 41 million people yearly, equivalent to 74% of all deaths globally.

A report by WHO in April 2022 highlighted the alarming rate of deaths from NCDs in Africa, and the NCDs are increasingly becoming the main cause of mortality in sub-Saharan Africa, where the diseases were responsible for 37% of deaths in 2019, rising from 24% in 2000.

This project aims to improve the health and well-being of populations by developing the capacity for high-quality research to inform improved prevention, diagnosis, and treatment of inter-connected NCDs (hypertension, diabetes and co-existing stress, anxiety, and depression).

Professor Faith Osier, President of the International Union of Immunological Societies and Chair of the NIHR Global Health Research Centres Funding Committee, said: “These new centres are truly ground-breaking - it’s the first time we’ve seen anything like this level of investment in non-communicable disease research in low and middle-income countries. The potential for this truly equitable partnership working between researchers in LMICs and in the UK is immense and we’re so excited to see the advances that the next five years will bring.”

fOR her part, Prof. Irene A. Agyepong, the Director for NIHR Global Health Research Centres West Africa, stated: “The 15 countries of ECOWAS, like most LMICs, are increasingly challenged by rising illness and deaths related to NCDs.  This is additional to their long-standing challenges from communicable diseases such as malaria and tuberculosis. Research is at the heart of the innovation needed to address these problems, and establishing the centre is a timely and welcome effort to make a difference”.

Professor Tolib Mirzoev, Co-Director for NIHR Global Health Research Centres West Africa, stated: “I am delighted to jointly lead the Stop-NCD programme together with Professor Agyepong from the GCPS. Our programme addresses an important and urgent need for high-quality research to improve the control of NCDs in West Africa. Through excellent science, comprehensive capacity strengthening and equitable partnerships involving research teams and key stakeholders, we will ensure the longer-term legacy of African-led research for improved policy and practice in NCD control.”

The official announcement and launch of the project was held in Accra, Ghana, on 4th October 2022, with the Ghana Minister of Health, Kwaku Agyemang-Manu, as the special guest of honour.

Also present were the representative of the Minister of Health for Niger, M. Sabo Hassane Adamou, Deputy Secretary General and the representative of the Minister of Health for Burkina Faso, Baperman Abdel Aziz Siri.

Scientists, researchers and officials in the health sector from the UK and various West African implementing countries were present in Accra to grace the occasion.